Global Cough Syrup Market to Reach US$ 7.3 Billion by 2028, Propelled by the Increasing Incidences of Upper Respiratory Tract Infection (URTI)

November 28, 2022 | Healthcare

The latest report by IMARC, titled “Cough Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, finds that the global cough syrup market size reached US$ 5.7 Billion in 2022. Cough syrup is a combination drug that offers temporary relief from common cold, cough, hay fever, and other respiratory allergies. It is produced using expectorants, non-opioid cough suppressants, and antihistamine compounds to block the symptoms. The suppressants help alleviate the symptoms of dry cough by reducing the activity of the cough reflex and minimizing the urge to cough. The function of the expectorants is to treat a cough with mucus by loosening it, which makes it easy to expel from the body. The antihistamines relieve the cough caused by minor throat or airway irritation. In recent years, cough syrups have gained traction as they are prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in different flavors, such as honey, bubblegum, cherry, and orange.

Global Cough Syrup Market Trends:

One of the primary factors driving the market is the increasing incidences of upper respiratory tract infection (URTI), along with other respiratory disorders globally. Additionally, the rising geriatric population, which is more prone to such diseases, is positively influencing market growth. Other than this, cough syrups are mainly used to treat dry cough, which develops due to prolonged exposure to tobacco, poor air quality, and indoor smoke and air pollution. Besides this, the growing health consciousness, along with the easy accessibility of this product in pharmacies and general stores, is creating a positive market outlook. In line with this, numerous product innovations, such as the development of cough syrups with minimal effects, are propelling market growth. Other growth-inducing factors include exponential growth in the pharmaceutical industry and expanding disposable income levels. Looking forward, IMARC Group expects the market value to reach US$ 7.3 Billion by 2028, expanding at a CAGR of 4.11% during the forecast period (2023-2028).

Market Summary:

  • Based on the product type, the market has been divided into expectorants, cough suppressants/antitussives, and combination medications.
  • On the basis of the age group, the market has been bifurcated into pediatric and adult.
  • Based on the distribution channel, the market has been segregated into retail, hospital, and online pharmacy.
  • Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson Private Limited, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi SA, Sun Pharmaceutical Industries Limited, and The Procter & Gamble Company.


Report Scope:
 

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Product Type, Age Group, Distribution Channel, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Limited and The Procter & Gamble Company
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Cough Syrup Market to Reach US$ 7.3 Billion by 2028, Propelled by the Increasing Incidences of Upper Respiratory Tract Infection (URTI)
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More